Research Article
Dipeptidyl Peptidase-4 Inhibitors as a Third-Line Oral Antihyperglycaemic Agent in Patients with Type 2 Diabetes Mellitus: The Impact of Ethnicity
Table 3
Demographic characteristics and clinical response: Asian versus non-Asian groups.
| | Asian | Non-Asian | Test statistics | | | |
| Age (years) | 61.6 ± 10.3 | 62.3 ± 8.3 | ; | Weight (kg) | 69.0 (60.2–77.6) | 89.0 (77.5–100.1) | ; | Body mass index (kg/m2) | 25.6 (24.0–27.5) | 31.6 (28.2–34.4) | ; | Diabetes duration (years) | 13.7 ± 5.8 | 11.7 ± 5.7 | ; | Duration on triple therapy (months) | 4.6 (3.7–6.4) | 4.5 (3.5–7.2) | ; | Baseline HbA1c | | | | (%) | 8.1 (7.6–8.7) | 8.3 (7.8–8.9) | ; | (mmol/mol) | 65 (60–72) | 67 (62–74) | Change in weight from baseline (kg) | −0.7 ± 1.6 | −1.0 ± 2.4 | ; | Change in HbA1c from baseline (%) | −1.00 (0.6–1.3) | −0.90 (0.4–1.6) | ; | Patients achieving a given HbA1c | | | | <7% (53 mmol/mol) | 39.0 | 25.6 | ; | <8% (64 mmol/mol) | 90.2 | 76.9 | ; |
|
|